Literature DB >> 25399848

Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.

Nasimudeen R Jabir1, Chelapram K Firoz, Saleh S Baeesa, Ghulam Md Ashraf, Suhail Akhtar, Warda Kamal, Mohammad A Kamal, Shams Tabrez.   

Abstract

Neurodegeneration is the progressive loss of neuronal structure and function, which ultimately leads to neurological disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis, and Huntington's disease. Even after the recent significant advances in neurobiology, the above-mentioned disorders continue to haunt the global population. Several studies have suggested the role of specific environmental and genetic risk factors associated with these disorders. However, the exact mechanism associated with the progression of these disorders still needs to be elucidated. In the recent years, sophisticated research has revealed interesting association of prominent neurodegenerative disorders such as AD and PD with chronic diseases such as cancer, diabetes, and cardiovascular diseases. Several common molecular mechanisms such as generation of free radicals, oxidative DNA damage, aberrations in mitochondrial DNA, and dysregulation of apoptosis have been highlighted as possible points of connection. The present review summarizes the possible mechanism of coexistence of AD and PD with other chronic diseases.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; Cancer; Cardiovascular disease; Neurodegenerative disorders; Parkinson's disease

Mesh:

Year:  2014        PMID: 25399848      PMCID: PMC6495953          DOI: 10.1111/cns.12344

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  8 in total

1.  Associations of ARHGAP26 Polymorphisms with Alzheimer's Disease and Cardiovascular Disease.

Authors:  Kesheng Wang; Yongke Lu; Deana F Morrow; Danqing Xiao; Chun Xu
Journal:  J Mol Neurosci       Date:  2022-02-16       Impact factor: 2.866

Review 2.  "Till Death Do Us Part": A Potential Irreversible Link Between Aberrant Cell Cycle Control and Neurodegeneration in the Adult Olfactory Bulb.

Authors:  Saad Omais; Carine Jaafar; Noël Ghanem
Journal:  Front Neurosci       Date:  2018-03-09       Impact factor: 4.677

Review 3.  A general neurologist's perspective on the urgent need to apply resilience thinking to the prevention and treatment of Alzheimer's disease.

Authors:  Grazyna Pomorska; Judith K Ockene
Journal:  Alzheimers Dement (N Y)       Date:  2017-09-12

Review 4.  Sleep Disorders Associated With Alzheimer's Disease: A Perspective.

Authors:  Anna Brzecka; Jerzy Leszek; Ghulam Md Ashraf; Maria Ejma; Marco F Ávila-Rodriguez; Nagendra S Yarla; Vadim V Tarasov; Vladimir N Chubarev; Anna N Samsonova; George E Barreto; Gjumrakch Aliev
Journal:  Front Neurosci       Date:  2018-05-31       Impact factor: 4.677

5.  Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.

Authors:  Farzaneh Ghazi Sherbaf; Bahram Mohajer; Amir Ashraf-Ganjouei; Mahtab Mojtahed Zadeh; Ali Javinani; Hossein Sanjari Moghaddam; Mehdi Shirin Shandiz; Mohammad Hadi Aarabi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-02       Impact factor: 5.555

6.  Synthesis and neuroprotective effects of the complex nanoparticles of iron and sapogenin isolated from the defatted seeds of Camellia oleifera.

Authors:  Qian Yang; Chuang Zhao; Jun Zhao; Yong Ye
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 7.  Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases.

Authors:  Francisco Miguel Gutierrez-Mariscal; Antonio Pablo Arenas-de Larriva; Laura Limia-Perez; Juan Luis Romero-Cabrera; Elena Maria Yubero-Serrano; Jose López-Miranda
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

Review 8.  Development of early diagnosis of Parkinson's disease: Illusion or reality?

Authors:  Michael Ugrumov
Journal:  CNS Neurosci Ther       Date:  2020-06-29       Impact factor: 7.035

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.